Abdul Rafeh Naqash, MD

Advanced Fellow Early Clinical Trials Development Program
National Cancer Institute
Bethesda
MD
Specialties
Hematology - Oncology

Abdul Rafeh Naqash is an advanced fellow in the Early Clinical Trials Development Program and the Developmental Therapeutics Clinic at the National Cancer Institute, Bethesda.


After receiving his medical degree at the Government Medical College Srinagar, Kashmir, Dr. Naqash pursued short-term research training at the National Institute of Immunology, New Delhi, and at the University of Buffalo, NY. He completed Internal Medicine residency training at the University of Buffalo/Catholic Health. Subsequently, Dr. Naqash completed his sub-specialty clinical training in Hematology/Oncology at East Carolina University, Greenville, NC. At the NCI, developmental therapeutics clinic Dr. Naqash is focusing his interest in drug development and incorporating a genomically driven approach to early phase clinical trials. He is also interested in immunotherapy biomarkers and immune toxicities. Dr. Naqash has been the recipient of several national awards, including the ASCO-SITC merit awards in 2018 and 2019, and the 2020 ASCO- Young Investigator Award. He was one of the 33 nationally selected early career investigators for the 2018 SITC Sparkathon. Dr. Naqash is an executive member of the SITC Early Career Scientist Committee and the ASCO Trainee and Early Career Council, where he is actively involved in working towards developing educational initiatives for early-career investigators.

Outside of work, Dr. Naqash enjoys traveling and spending time with this wife and eighteen-month-old daughter.

Conflict of Interest

None

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical trials.

 

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical trials.

 

Forum Discussions

Original post date: 2022-02-21

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12
Original post date: 2022-02-01

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the

Last Activity: Tue, 02/01/2022 - 16:16
Original post date: 2021-11-24

The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!

Image
Happy Thanksgiving!
Last Activity: Thu, 12/02/2021 - 15:33
Original post date: 2021-01-07
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about

Last Activity: Thu, 01/07/2021 - 15:55

Comments

Post Date: 2022-04-12

You may find our clinical trial page helpful, also.  https://cancergrace.org/find-clinical-trials.  

Post Date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 


This comment has been promoted to its

Post Date: 2021-12-02

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that

Post Date: 2021-07-19

Hi all!  

The 2021 Targeted Therapies Patient Forum is now available ON Demand!  

Click below to